Stocks and Investing Stocks and Investing
Tue, May 30, 2023
[ 12:00 AM ] - WOPRAI
Bill Kirk Upgraded (STZ) to Strong Buy and Increased Target to $270 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Gregory Pardy Maintained (SU) at Buy with Decreased Target to $51 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Brad Heffern Maintained (SUI) at Buy with Decreased Target to $153 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
James Feldman Maintained (SUI) at Hold with Decreased Target to $140 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Patrick Scholes Maintained (CCL) at Strong Sell with Increased Target to $11 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Gavin Clark-Gartner Maintained (CCCC) at Buy with Decreased Target to $10 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (STEP) at Hold with Decreased Target to $26 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Patrick Wood Initiated (STE) at Hold and Held Target at $206 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Gavin Clark-Gartner Maintained (SRPT) at Buy with Decreased Target to $151 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Ronald Epstein Maintained (SPR) at Sell with Decreased Target to $25 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Yasmeen Rahimi Initiated (SLRN) at Buy and Held Target at $68 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Tyler Van Buren Initiated (SLRN) at Buy on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Akash Tewari Initiated (SLRN) at Strong Buy and Held Target at $31 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Vikram Purohit Initiated (SLRN) at Buy and Held Target at $29 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Casey Alexander Maintained (SLRC) at Hold with Decreased Target to $15 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Jake Bartlett Maintained (CBRL) at Hold with Decreased Target to $103 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Kevin Dede Reiterated (CAN) at Strong Buy and Held Target at $4 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Patrick Wood Initiated (BSX) at Buy and Held Target at $58 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Reiterated (BTAI) at Strong Buy and Held Target at $66 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Mauricio Serna Maintained (BKE) at Hold with Decreased Target to $35 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Kuske Reiterated (BIP) at Buy and Held Target at $44 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Patrick Wood Initiated (BLCO) at Hold and Held Target at $20 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Marc Bianchi Maintained (APD) at Buy with Increased Target to $385 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Justin Patterson Reiterated (ANGI) at Buy and Held Target at $3 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
James Feldman Maintained (AMH) at Hold with Increased Target to $36 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Andrew Kuske Reiterated (AQN) at Buy and Held Target at $11 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Clarke Jeffries Reiterated (WIX) at Buy and Held Target at $120 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Anthony Crowdell Maintained (XEL) at Strong Buy with Decreased Target to $69 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Derrick Whitfield Maintained (WTI) at Strong Buy with Decreased Target to $7.9 on, May 30th, 2023
[ 12:00 AM ] - WOPRAI
Matthew Barcus Reiterated (XLO) at Strong Buy and Held Target at $7 on, May 30th, 2023

Matthew Barcus Reiterated (XLO) at Strong Buy and Held Target at $7 on, May 30th, 2023


Published on 2024-10-28 04:04:45 - WOPRAI, Matthew Barcus
  Print publication without navigation


Matthew Barcus of Chardan Capital, Reiterated "Xilio Therapeutics, Inc." (XLO) at Strong Buy and Held Target at $7 on, May 30th, 2023.

Matthew, nor any peers, have made any analyst calls on XLO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources